Early-Onset Alzheimer's Shows Faster Tau Spread
Adults diagnosed before age 65 may need treatments that target tau as well as amyloid, the study suggests.
Updated on Nov. 4, 2026 in Alzheimer’s
Live Poll
Would you see a doctor about vision or speech changes in midlife?
Researchers report that early-onset Alzheimer's, which begins before age 65, shows more aggressive tau accumulation in the brain than late-onset Alzheimer's. The study compared 390 patients averaging age 59 with 211 patients averaging age 78, all with mild cognitive impairment or mild dementia, and the findings may matter most for younger people with the disease.
Why it matters
Tau is a protein that builds up inside brain cells in Alzheimer's, and the finding suggests that younger patients may need treatment strategies that address tau as well as amyloid. The results point toward clinical trials that combine amyloid-targeting and tau-targeting approaches for younger patients.
The study used PET brain scans in 390 early-onset and 211 late-onset Alzheimer's patients, with some participants scanned repeatedly over two to three years to track tau changes. Tau accumulated at more than twice the rate in the younger group, and it spread more widely through the brain.
The players
Karolinska Institutet
The Stockholm-based medical university whose researchers led the study, known for its neuroscience and dementia research.
University of California San Francisco
A major academic medical center whose co-authors contributed to the study, with a long-standing research program in neurodegenerative disease.
The details
Alzheimer's involves two abnormal proteins in the brain, amyloid and tau, and the study used PET scans to track how each builds up over time. In the younger patients, tau deposits were more numerous and spread more widely across brain regions than in older patients. Because early-onset patients often present with non-memory symptoms, the disease can be harder to recognize at first.
Timeline
Study results were published on November 4, 2026, in Science Translational Medicine.
UK dementia cases are projected to reach 1.4 million by 2040.
Health Landscape
The projected rise in UK dementia cases to 1.4 million by 2040 is driving interest in treatments that target more than one pathway. This study suggests that the amyloid-focused approach may need to be paired with tau-targeting strategies, particularly for the younger patients who make up part of the growing caseload.
If you or a family member are under 65 and experiencing memory or non-memory changes such as language, vision, or planning difficulties, it is worth raising these symptoms with a doctor rather than assuming they are stress. Early evaluation can open the door to specialist assessment and, where appropriate, clinical trial discussions.
The takeaway
Early-onset Alzheimer's appears to involve faster tau spread than later-onset disease, which is a useful reason to discuss unusual cognitive or non-memory symptoms with a physician sooner. Ask your doctor whether specialist memory assessment is appropriate if symptoms begin before age 65.
Further reading
For more background on how the disease progresses, see our Alzheimer’s coverage.
Live Poll
Would you see a doctor about vision or speech changes in midlife?
